These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4136315)

  • 21. [Rivaroxaban: mode of action].
    Drouet L
    Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S9-15. PubMed ID: 19185786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study of a new antivitamin K: 6134 M.D. 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol].
    Pernod J; Kermarec J; Migne J
    Therapie; 1968; 23(3):567-74. PubMed ID: 4906093
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of new anticoagulants: present and future.
    Harenberg J
    Semin Thromb Hemost; 2008 Nov; 34(8):779-93. PubMed ID: 19214916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and safety of vitamin K-antagonists in an anticoagulant clinic.
    Skov J; Ibrahim S; Jespersen J
    Thromb Res; 2016 Nov; 147():122-123. PubMed ID: 27736704
    [No Abstract]   [Full Text] [Related]  

  • 25. [Preventive anticoagulant treatment in surgery. Indications--technics].
    Nicolas F
    Anesth Analg (Paris); 1967; 24(5):497-505. PubMed ID: 5593939
    [No Abstract]   [Full Text] [Related]  

  • 26. Recent advances in the control of anticoagulant therapy.
    Owren PA
    Geriatrics; 1971 Aug; 26(8):74 passim. PubMed ID: 5096463
    [No Abstract]   [Full Text] [Related]  

  • 27. The safety of fondaparinux for the prevention and treatment of venous thromboembolism.
    Turpie AG
    Expert Opin Drug Saf; 2005 Jul; 4(4):707-21. PubMed ID: 16011449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anticoagulant treatment and digestive hemorrhages].
    Himbert J; Sée E; Thiroloix P; Lenègre J
    Ann Med Interne (Paris); 1971 Nov; 122(11):1055-64. PubMed ID: 5317109
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative evaluation of aspirin and indirect-action anticoagulants in the prevention of venous thromboses in traumatology and orthopedic practice].
    Lavrinovich TS; Petukhova LI; Slutskiĭ LI
    Ortop Travmatol Protez; 1976 Oct; (10):35-9. PubMed ID: 1004825
    [No Abstract]   [Full Text] [Related]  

  • 30. Travel and oral anticoagulation.
    Ringwald J; Strobel J; Eckstein R
    J Travel Med; 2009; 16(4):276-83. PubMed ID: 19674269
    [No Abstract]   [Full Text] [Related]  

  • 31. Practical aspects of the oral new anticoagulants.
    DeLoughery TG
    Am J Hematol; 2011 Jul; 86(7):586-90. PubMed ID: 21674571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of oral anticoagulant treatment on D-dimers levels].
    Ombandza-Moussa E; Samama MM; Horellou MH; Chatelier AL; Elalamy I; Conard J
    Ann Biol Clin (Paris); 2001; 59(5):579-83. PubMed ID: 11602388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current practice with vitamin K antagonist therapy.
    Kazmier FJ
    Mayo Clin Proc; 1974 Dec; 49(12):918-22. PubMed ID: 4216730
    [No Abstract]   [Full Text] [Related]  

  • 34. [The anticoagulation clinic: that can not be ignored].
    Boccalon H
    Ann Cardiol Angeiol (Paris); 2006 Jan; 55(1):22-6. PubMed ID: 16457032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anticoagulant prophylaxis: from clinical trials to clinical practice].
    Scardi S; Mazzone C
    G Ital Cardiol; 1998 Feb; 28(2):178-86. PubMed ID: 9534059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Before administering oral anticoagulant therapy with vitamin K antagonists, should heparin be administered, even when therapy is purely of preventive intent without an acute clinical manifestation?].
    Seitz R
    Internist (Berl); 1995 Nov; 36(11):1099-100. PubMed ID: 8543448
    [No Abstract]   [Full Text] [Related]  

  • 37. Current strategies in prophylaxis and treatment of venous thromboembolism.
    Schulman S
    Ann Med; 2008; 40(5):352-9. PubMed ID: 18484347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anticoagulants in pregnancy and puerperium].
    Ludwig H
    Geburtshilfe Frauenheilkd; 1970 Apr; 30(4):337-47. PubMed ID: 4193743
    [No Abstract]   [Full Text] [Related]  

  • 39. [Duration of antivitamin K treatment in venous thromboembolic disease].
    Pinede L; Ninet J
    Arch Mal Coeur Vaiss; 1996 Jul; 89(7):927-31. PubMed ID: 8869257
    [No Abstract]   [Full Text] [Related]  

  • 40. [Indications for anticoagulants].
    Oger E; Mottier D
    Rev Prat; 1999 Oct; 49(15):1648-53. PubMed ID: 10581995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.